March 9, 2026 Deal with Novo Nordisk: In a significant pivot, Novo Nordisk and Hims & Hers announced an agreement on March 9, 2026, to offer various doses of Ozempic through the Hims platform for direct-to-consumer customers, effectively moving Hims away from compounded semaglutide toward branded, FDA-approved medication access
The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression
This blog breaks down what they are, how they compare, and which patients benefit most, all from a medical professional standpoint
7 Recognising these associations is important in primary care, as metabolic risk factors are common, potentially modifiable and may provide an opportunity to improve both fertility and long-term health outcomes
Did you know
So it's like we need both of these parts so importantly and neither one without the other is going to work